Neurogene (NGNE) Provides Update on NGN-401 Gene Therapy Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to Neurogene (NGNE) Provides Update on NGN-401 Gene Therapy Trial
(NASDAQ: NGNE) Delayed: 38.60 +0.99 (2.63%)
Previous Close $37.61    52 Week High $ 
Open $37.25    52 Week Low $ 
Day High $39.38    P/E N/A 
Day Low $36.56    EPS $ 
Volume 205,635